Objective: Contrast-enhanced MRI is considered problematic in renal allograft recipients because of the development of nephrogenic systemic fibrosis. Therefore, we assessed the clinical value of a monoexponential model and a distribution function model of diffusion-weighted imaging (DWI) in renal allografts.
Materials And Methods: A total of 23 patients were divided into three groups, as follows: group A, stable renal allograft function for at least 6 months; group B, transplantation within the past 30 days, with good renal allograft function; and group C, an acute deterioration or decrease in renal allograft function. T2-weighted axial, T1-weighted coronal, and a paracoronal DWI sequences with 16 b values (b = 0-750 s/mm(2)) were performed on a 1.5-T scanner. Region of interest-based analysis of the apparent diffusion coefficient (ADC) of the renal cortex was used.
Results: Monoexponential analysis showed mean (± SD) ADC values of 1932 ± 98, 2095 ± 246, and 1636 ± 200 10-(6) mm(2)/s for patient groups A, B, and C, respectively. The distribution function revealed a mean ADC of 2487 ± 185, 2850 ± 325, and 2142 ± 31410-(6) mm(2)/s for groups A, B, and C, respectively. The difference between groups A and B combined and group C (p < 0.005) was statistically significant for both models. R(2) yielded the best regression of mathematic fitting for the distribution function model (p < 0.0001).
Discussion: Unenhanced evaluation of renal allografts with DWI correlated well with renal function for both the monoexponential analysis and the distribution function model. There was no statistically significant difference in ADC values and renal allograft function between both types of analysis, but the distribution function showed the best regression.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2214/AJR.10.5775 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Evaluation of Serum KIM-1 in a Pediatric Cohort of Renal Transplantation-A Pilot Study.
Children (Basel)
January 2025
Department of Pediatric Nephrology, Cluj-Napoca Children's Hospital Gheorghieni, 400023 Cluj-Napoca, Romania.
Introduction: Renal transplantation ensures particular advantages for patients with end-stage kidney disease. However, in some cases, early complications may result in allograft dysfunction, which can ultimately lead to the loss of the graft. Creatinine is a poor biomarker for kidney injury due principally to its inability to help diagnose early acute renal failure and complete inability to help differentiate among its various causes.
View Article and Find Full Text PDFCan you have a cake and eat it? Comparing reducing mycophenolate versus switching to everolimus for kidney transplants with new-onset BKPyV-DNAemia.
Kidney Int
February 2025
Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel Switzerland. Electronic address:
BK polyomavirus remains a vexing issue in kidney transplantation. There are no antiviral drugs, and solely reducing immunosuppression is recommended for management. However, evidence from randomized controlled studies lacks defining clearance of BK polyomavirus-DNAemia and/or nephropathy as a primary outcome.
View Article and Find Full Text PDFDownregulation of N6-Methyladenosine (m6A) Methylation of Sema4D mRNA Contributes to Treg Dysfunction and Allograft Rejection.
Am J Transplant
January 2025
Department of Gastrointestinal Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan Province, China; Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Chengdu, Sichuan Province, China. Electronic address:
Regulatory T cells (Tregs) has been shown to be involved in the induction of transplantation tolerance in numerous models. Our previous work demonstrated that METTL14 loss impaired Treg function and hindered the establishment of transplantation tolerance. However, the underlying mechanisms remain unclear.
View Article and Find Full Text PDFDonor hepatitis C status is not associated with an increased risk of acute rejection in kidney transplantation.
Surg Pract Sci
March 2024
Department of Surgery, Division of Multiorgan Transplant and Hepatobiliary Surgery, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, 77555-0655, USA.
Introduction: In renal transplantation, donor hepatitis C virus (HCV) status is crucial to consider when selecting a recipient given the high likelihood of transmission. We analyzed the effect of donor HCV status on post-renal transplant rejection and virologic infectious outcomes using electronic health record data from multiple US health care organizations.
Methods: Using real world data from electronic health records of renal transplant recipients, a propensity score-matched case-control study of one-year renal transplant outcomes was conducted on cohorts of HCV-negative recipients who received an organ from an HCV-positive donor (HCV D+/R-) versus from an HCV-negative donor (HCV D-/R-).
Long-term Metabolic Outcomes Post-Simultaneous Pancreas-Kidney Transplantation in Recipients With Type 1 Diabetes.
Transplantation
January 2025
Faculty of Medicine and Health, University of Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Background: Simultaneous pancreas-kidney (SPK) transplantation is an effective treatment option for type 1 diabetes mellitus and concurrent end-stage kidney disease. However, the diabetogenic effects of immunosuppression can counteract the beneficial effects of sustained normoglycemia. Long-term metabolic trends that reflect cardiovascular risk are reported poorly in the literature.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!